CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer

Abstract

Polymorphisms in genes encoding CD28, ICOS, and CTLA-4 were demonstrated to be associated with susceptibility to malignancies. To the best of our knowledge, no study on this association has been performed in a Caucasian population for non-small-cell lung cancer (NSCLC). In the present work, we investigated the polymorphisms CTLA-4c.49 A> G (rs231775), CTLA-4g.319C> T (rs5742909), CTLA-4g. *642AT(8_33), CTLA- 4g.*6230G>A (CT60) (rs3087243), CTLA- 4g.*10223G>T (Jo31) (rs11571302), CD28c.17+3T> C (rs3116496), and ICOSc.1554+4GT(8_15) in 208 NSCLC patients and 326 controls. The distributions of the allele and genotype were similar in both groups for CTLA-4, CD28, and ICOS gene polymorphisms. However, we noted a tendency toward overrepresentation of individuals possessing the CTLA- 4c.49A>G[A] allele in NSCLC patients compared with controls (0.84 vs 0.79, p = 0.09). The association became significant compared with controls in women for the CTLA- 4c.49A>G[A] allele and CTLA- 4c.49A>G[AA] genotype (0.67 vs 0.54, p = 0.01, and 0.47 vs 0.30, p = 0.02; respectively). Moreover, the constellation of alleles C TLA- 4c.49A>G[A]/CT60[G]/ CD28c.17+3T>C[T]/ ICOSc.1554+4GT(8_15)[>10] increased the risk of NSCLC about 2-fold ( p = 0.002). The same constellation of alleles combined with smoking, CTLA-4g.319C> T[T], and ICOSc.1554+4GT(8_15)[>10] was associated with a decreased overall survival rate. In conclusion, the constellation of specific alleles in CTLA-4, CD28, and ICOS genes contributes to the susceptibility and clinical course of NSCLC.